Responses
Oral Presentations
Can we treat OA as an inflammatory disease?
OP0018 A Randomized, Multicentre, Double Blind, Placebo Controlled Study of Anti Tnf Alpha (Adalimumab) in Refractory Hand Osteoarthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.